CFMS
still within its "gap zone" from when it gapped down previously. However, the price continued higher today. But volume is a bit slower on Wednesday. Can this technically continue higher if volume continues to be this low compared to Tuesday?
"It emerged that the company entered into a lucrative agreement with Stryker Corporation. Stryker is one of the world’s foremost medical technology companies. According to the terms of the deal, Conformis is going to both sell and license its products to Stryker. Conformis is going to be paid $14 million by Stryker straightaway and stands to be paid $16 million more if certain targets are met. It is a significant deal and one that could be a key focus for the market."*
About CFMS
Conformis Inc is a US-based medical technology company. It uses iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of knee replacement market. Its total revenue generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Quote Source: 3 Robinhood Penny Stocks To Watch In October
"It emerged that the company entered into a lucrative agreement with Stryker Corporation. Stryker is one of the world’s foremost medical technology companies. According to the terms of the deal, Conformis is going to both sell and license its products to Stryker. Conformis is going to be paid $14 million by Stryker straightaway and stands to be paid $16 million more if certain targets are met. It is a significant deal and one that could be a key focus for the market."*
About CFMS
Conformis Inc is a US-based medical technology company. It uses iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of knee replacement market. Its total revenue generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Quote Source: 3 Robinhood Penny Stocks To Watch In October